ICMR Chief Balram Bhargava on need for booster shots: No scientific evidence

Dr Balram Bhargava, the head of the Indian Council of Medical Research (ICMR), has said that there is no scientific evidence to yet to support the necessity for a booster vaccination dosage to provide further protection against the coronavirus illness (Covid-19). “Administering the second dose of Covid-19 vaccine to all adult population, and ensuring that not only India, but the entire world gets vaccinated, is the priority of the government for now,” the ICMR director general (DG) said.

“More so, there is no scientific evidence so far to support the need for a booster vaccine dose against Covid-19,” Bhargava told news agency PTI on Sunday.

The senior scientist’s remarks come in the backdrop of recent reports that the National Technical Advisory Group on Immunization (NTAGI), the Centre’s top expert panel on immunisation, is likely to meet in the last week of November to discuss key issues such as booster shots, as well as opening up the vaccination for children.

In recent days, several people, including Rajasthan chief minister Ashok Gehlot, have urged the Union government to permit the boosters.

“The Centre cannot take a direct decision in such a matter. When the ICMR says that a booster shots should be given, we will consider it then. At present, the aim is to complete full vaccination of the target population. Once that is done, a decision on boosters will be taken. We have enough stocks available,” Union health minister Mansukh Mandaviya said recently.

According to official data, out of 940 million eligible adults, around 82 per cent have taken their first dose of a Covid-19 jab, while nearly 43 per cent have taken both doses, or, in other words, are fully inoculated.

The nationwide vaccination drive against this viral illness began on January 16 this year. Till now, nearly 1.17 billion doses have been administered.

AddThis Website Tools
Medically Speaking

Recent Posts

Mounjaro Launched in India: Price & Impact on Diabetes and Obesity

Eli Lilly, a leading American pharmaceutical company, has launched its groundbreaking diabetes and obesity medication,…

1 day ago

Shocking Rabies Case in Greater Noida Challenges Common Misconceptions

A recent case of rabies transmission in Greater Noida has sent shockwaves through the community,…

1 day ago

Punjab Government to Ban Energy Drinks in Schools and Colleges for Student Health

The Punjab government is set to ban high-caffeine energy drinks in schools, citing severe health…

1 day ago

Experts Warn of Global Threat from Chronic Wasting Disease

Chronic Wasting Disease (CWD) is a highly contagious and fatal neurological disorder that affects deer,…

2 days ago

CDC Reschedules Vaccine Advisory Meeting to April 15-16

The Centers for Disease Control and Prevention (CDC) has announced a rescheduling of its vaccine…

2 days ago

India’s Specialty Chemicals Rebound, Pharma Exports Surge

India’s specialty chemicals industry and pharmaceutical exports continue to showcase resilience amid global uncertainties. As…

2 days ago